Cite
Disparate Eosinophilic Phenotypes with Age: Impact on Eligibility for Anti-IL-5 Therapies in Severe Asthma
MLA
Pieter-Paul Hekking, and W. Gerald Teague. “Disparate Eosinophilic Phenotypes with Age: Impact on Eligibility for Anti-IL-5 Therapies in Severe Asthma.” The Journal of Allergy and Clinical Immunology. In Practice, vol. 7, no. 8, July 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....71e9788fb052e0df7a34cfa1d55cf947&authtype=sso&custid=ns315887.
APA
Pieter-Paul Hekking, & W. Gerald Teague. (2019). Disparate Eosinophilic Phenotypes with Age: Impact on Eligibility for Anti-IL-5 Therapies in Severe Asthma. The Journal of Allergy and Clinical Immunology. In Practice, 7(8).
Chicago
Pieter-Paul Hekking, and W. Gerald Teague. 2019. “Disparate Eosinophilic Phenotypes with Age: Impact on Eligibility for Anti-IL-5 Therapies in Severe Asthma.” The Journal of Allergy and Clinical Immunology. In Practice 7 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....71e9788fb052e0df7a34cfa1d55cf947&authtype=sso&custid=ns315887.